drugset / Trial / NCT00436540

A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam

NCT00436540

Phase 4 Completed 78 enrolled Galderma R&D
RandomizedParallel-groupSingle-blindTreatment

Summary

The primary objective of this study is to evaluate the efficacy and safety of clobetasol propionate 0.05% (Clobex®) spray compared to clobetasol propionate 0.05% (Olux®) foam.

Timeline

Start
2006-03
Primary completion
2007-01
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator clobetasol propionate Small molecule 0.05 % Topical

Indications